Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

JOHNSON & JOHNSON Director's Dealing 2024

Feb 13, 2024

29750_dirs_2024-02-12_8e35852f-baf0-4015-8266-b00679e75499.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2024-02-08

Reporting Person: Schmid Timothy (EVP, WW Chair, MedTech)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-02-08 Common Stock M 1964.0000 $0.0000 Acquired 10943.0000 Direct
2024-02-08 Common Stock F 1001.0000 $156.3300 Disposed 9942.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-02-08 Restricted Share Units $ M 1964.0000 Disposed 2024-02-08 Common Stock (1964.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 700.0000 Indirect
Common Stock 46.0000 Indirect

Footnotes

F1: Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.

F2: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

F3: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).

F4: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).